Direction du développement et de la coopération

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 2

Netcell strengthening malaria control in Tanzania

  • reduce illness and deaths caused by malaria by supporting National Malaria Control Program (NMCP) within the Ministry of Health
  • technical assistance to the National Malaria Control provided by Swiss TPH
  • contribution to reducing childhood mortality by 63% over the past two decades.
Pays

tanzania

Impact

Population covered: 5.3 million (11% of Tanzanian population); Malaria deaths reduced by 50% between 2005-2016; 87 million nets distributed, saving approx. 60,000 lives of children < 5 years

Durée

NMCP support since 2002, current contribution 2013-2019 (6.25 million)

Activité

Vector control

L'Institut Tropical et de Santé Publique Suisse

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 2

RTS,S: most advanced candidate for a malaria vaccine. Swiss TPH helped coordinate a large-scale clinical trail involving more than 16,000 children. Swiss TPH also calculated the long-term impact and cost-effectiveness of RTS,S in 43 African countries.

Pays

burkina-faso gabon ghana kenya malawi mozambique tanzania

Impact

16,000 children

Durée

2009 - 2014

Activité

Innovation & Research

Medicines for Malaria Venture

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 2

Supporting development of a key easy-to-administer and long-protective antimalarial - dihydroartemisinin-piperaquine (Euroartesim).

Pays

indonesia mozambique tanzania zambia

Durée

Ongoing

Activité

Treatment

SolidarMed

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.


Project 1

Primary health care in 3 districts in rural Tanzania: improving access to early diagnosis and treatment, sensitization / IEC.

Pays

tanzania

Impact

745,000 persons

Durée

2009 - ongoing

Activité

Diagnosis & Treatment

Syngenta

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.


Project 1

Launch of ACTELLIC 300CS for IRS & following establishment of NgenIRS project. The project's aim is to make the most effective, long lasting insecticides available to malaria control programmes to support insecticide resistance management strategies.

Pays

benin burkina-faso ethiopia ghana kenya madagascar mali malawi mozambique rwanda tanzania uganda zambia zimbabwe

Impact

6.7 million units of ACTELLIC procured

Durée

2013/2016 - ongoing

Activité

Vector control

Unisanté

The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.

Project 1

Usefulness of antimalarial drug concentrations in blood as a monitoring tool for evaluating population drug usage in relation to diagnosis and treatment environment.

Pays

tanzania

Impact

6,000 Personen

Durée

4 Jahre

Activité

Innovation & Research

Project 2

Residual antimicrobial drug concentrations in blood as a monitoring tool for evaluating population medicine usage and the impact of stewardship interventions on drug pressure.

Pays

tanzania

Impact

9,000 persons

Durée

4 years

Activité

Innovation & Research